US Stock MarketDetailed Quotes

Amneal Pharmaceuticals (AMRX)

Watchlist
  • 13.190
  • -0.060-0.45%
Close Jan 15 16:00 ET
  • 13.170
  • -0.020-0.15%
Pre 07:24 ET
4.15BMarket Cap1319.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amneal Pharmaceuticals (AMRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
11.68%784.51M
3.24%724.51M
5.50%695.42M
16.73%2.79B
18.40%730.52M
13.29%702.47M
17.15%701.78M
18.23%659.19M
8.20%2.39B
1.18%616.98M
Operating revenue
11.68%784.51M
3.24%724.51M
5.50%695.42M
16.73%2.79B
18.40%730.52M
13.29%702.47M
17.15%701.78M
18.23%659.19M
8.20%2.39B
1.18%616.98M
Cost of revenue
17.93%510.54M
-3.01%438.26M
4.37%439.53M
12.74%1.77B
9.48%467.65M
11.72%432.91M
19.21%451.83M
11.01%421.13M
10.19%1.57B
8.31%427.15M
Gross profit
1.64%273.97M
14.53%286.25M
7.49%255.89M
24.36%1.02B
38.48%262.87M
15.92%269.56M
13.60%249.95M
33.60%238.06M
4.57%820.57M
-11.87%189.83M
Operating expense
12.59%203.49M
13.47%174.25M
1.30%154.97M
12.86%673M
19.39%185.73M
16.34%180.73M
6.49%153.56M
8.34%152.98M
0.09%596.32M
8.06%155.57M
Selling and administrative expenses
16.11%137.82M
6.70%124.27M
5.06%118.29M
10.88%476.44M
18.06%128.69M
5.03%118.69M
10.32%116.46M
10.28%112.6M
7.50%429.68M
6.70%109M
Research and development costs
4.32%65.79M
34.73%49.98M
3.79%41.81M
17.15%196.56M
20.52%56.12M
49.23%63.06M
-3.94%37.1M
-0.13%40.28M
-16.13%167.78M
7.62%46.56M
Other taxes
----
----
----
1,522.28%50.68M
1,870.48%23.96M
1,573.12%11.33M
3,219.51%13.44M
135.84%1.95M
395.09%3.12M
--1.22M
Other operating expenses
88.64%-117K
----
-5,222.00%-5.12M
----
----
-1,510.96%-1.03M
----
108.17%100K
71.26%-1.14M
--0
Operating profit
-20.65%70.49M
16.20%112.01M
18.61%100.92M
54.94%347.44M
125.16%77.14M
15.08%88.83M
27.13%96.39M
130.08%85.08M
18.70%224.25M
-52.03%34.26M
Net non-operating interest income expense
-43.76%-94.18M
0.94%-65.1M
13.34%-56.94M
-2.85%-258.6M
38.55%-61.66M
-28.68%-65.51M
-29.22%-65.72M
-33.23%-65.7M
-58.47%-251.43M
-112.08%-100.35M
Non-operating interest expense
-4.12%62.81M
-0.94%65.1M
-13.34%56.94M
22.77%258.6M
3.55%61.66M
28.68%65.51M
29.22%65.72M
33.23%65.7M
32.99%210.63M
26.62%59.55M
Total other finance cost
--31.37M
----
----
----
----
----
----
----
13,922.34%40.81M
----
Other net income (expense)
333.84%18.47M
146.82%4.81M
93.16%-6.49M
-999.35%-143.86M
-77.31%-30.8M
-137.53%-7.9M
-318.50%-10.27M
-3,362.36%-94.9M
95.30%-13.09M
45.32%-17.37M
Gain on sale of security
-250.88%-3.43M
3,251.15%8.26M
454.80%4.25M
-509.69%-6.85M
-434.83%-7.66M
177.37%2.27M
-162.23%-262K
-162.97%-1.2M
113.52%1.67M
302.11%2.29M
Special income (charges)
282.07%20.67M
64.81%-5.05M
88.49%-11.26M
-546.94%-148.8M
-18.91%-25.31M
-411.26%-11.35M
-472.10%-14.36M
-2,812.63%-97.78M
91.92%-23M
40.92%-21.28M
-Less：Restructuring and merger&acquisition
-16.86%143K
365.45%1.02M
-61.16%571K
111.18%1.43M
96.79%-437K
-95.87%172K
103.50%220K
-50.46%1.47M
-545.58%-12.75M
-683.52%-13.6M
-Less:Other special charges
-286.15%-20.81M
-71.51%4.03M
-88.90%10.69M
312.25%147.37M
-26.19%25.74M
675.30%11.18M
483.94%14.14M
24,594.10%96.31M
-87.31%35.75M
3.51%34.88M
Other non- operating income (expenses)
4.84%1.24M
-63.21%1.6M
-87.28%518K
42.93%11.78M
33.50%2.17M
-35.77%1.18M
945.56%4.36M
-6.71%4.07M
-55.36%8.24M
-55.96%1.63M
Income before tax
-133.87%-5.22M
153.42%51.71M
149.64%37.49M
-36.61%-55.01M
81.65%-15.32M
-32.82%15.42M
-31.20%20.41M
-701.21%-75.52M
83.77%-40.27M
-990.28%-83.46M
Income tax
-737.07%-23.36M
345.02%16.1M
109.03%12.87M
123.18%18.86M
-45.13%5.42M
276.59%3.67M
15,830.43%3.62M
821.56%6.16M
26.87%8.45M
649.97%9.88M
Net income
54.22%18.13M
112.13%35.61M
130.14%24.62M
-51.63%-73.88M
77.78%-20.74M
-53.03%11.76M
-43.45%16.79M
-709.17%-81.68M
80.88%-48.72M
-1,493.44%-93.34M
Net income continuous Operations
54.22%18.13M
112.13%35.61M
130.14%24.62M
-51.63%-73.88M
77.78%-20.74M
-53.03%11.76M
-43.45%16.79M
-709.17%-81.68M
80.88%-48.72M
-1,493.44%-93.34M
Minority interest income
32.32%15.76M
22.24%13.19M
24.67%12.42M
21.94%43.01M
94.89%10.34M
-22.40%11.91M
-39.25%10.79M
416.25%9.97M
128.26%35.27M
447.87%5.31M
Net income attributable to the parent company
1,618.59%2.37M
273.99%22.42M
113.31%12.2M
-39.16%-116.89M
68.49%-31.08M
-101.61%-156K
-49.70%5.99M
-1,219.93%-91.64M
35.38%-83.99M
-2,176.69%-98.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1,618.59%2.37M
273.99%22.42M
113.31%12.2M
-39.16%-116.89M
68.49%-31.08M
-101.61%-156K
-49.70%5.99M
-1,219.93%-91.64M
35.38%-83.99M
-2,176.69%-98.65M
Basic earnings per share
0.01
250.00%0.07
113.33%0.04
20.83%-0.38
75.00%-0.1
0
-75.00%0.02
-500.00%-0.3
44.19%-0.48
-1,233.33%-0.4
Diluted earnings per share
0.01
250.00%0.07
113.33%0.04
20.83%-0.38
75.00%-0.1
0
-75.00%0.02
-500.00%-0.3
44.19%-0.48
-1,233.33%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 11.68%784.51M3.24%724.51M5.50%695.42M16.73%2.79B18.40%730.52M13.29%702.47M17.15%701.78M18.23%659.19M8.20%2.39B1.18%616.98M
Operating revenue 11.68%784.51M3.24%724.51M5.50%695.42M16.73%2.79B18.40%730.52M13.29%702.47M17.15%701.78M18.23%659.19M8.20%2.39B1.18%616.98M
Cost of revenue 17.93%510.54M-3.01%438.26M4.37%439.53M12.74%1.77B9.48%467.65M11.72%432.91M19.21%451.83M11.01%421.13M10.19%1.57B8.31%427.15M
Gross profit 1.64%273.97M14.53%286.25M7.49%255.89M24.36%1.02B38.48%262.87M15.92%269.56M13.60%249.95M33.60%238.06M4.57%820.57M-11.87%189.83M
Operating expense 12.59%203.49M13.47%174.25M1.30%154.97M12.86%673M19.39%185.73M16.34%180.73M6.49%153.56M8.34%152.98M0.09%596.32M8.06%155.57M
Selling and administrative expenses 16.11%137.82M6.70%124.27M5.06%118.29M10.88%476.44M18.06%128.69M5.03%118.69M10.32%116.46M10.28%112.6M7.50%429.68M6.70%109M
Research and development costs 4.32%65.79M34.73%49.98M3.79%41.81M17.15%196.56M20.52%56.12M49.23%63.06M-3.94%37.1M-0.13%40.28M-16.13%167.78M7.62%46.56M
Other taxes ------------1,522.28%50.68M1,870.48%23.96M1,573.12%11.33M3,219.51%13.44M135.84%1.95M395.09%3.12M--1.22M
Other operating expenses 88.64%-117K-----5,222.00%-5.12M---------1,510.96%-1.03M----108.17%100K71.26%-1.14M--0
Operating profit -20.65%70.49M16.20%112.01M18.61%100.92M54.94%347.44M125.16%77.14M15.08%88.83M27.13%96.39M130.08%85.08M18.70%224.25M-52.03%34.26M
Net non-operating interest income expense -43.76%-94.18M0.94%-65.1M13.34%-56.94M-2.85%-258.6M38.55%-61.66M-28.68%-65.51M-29.22%-65.72M-33.23%-65.7M-58.47%-251.43M-112.08%-100.35M
Non-operating interest expense -4.12%62.81M-0.94%65.1M-13.34%56.94M22.77%258.6M3.55%61.66M28.68%65.51M29.22%65.72M33.23%65.7M32.99%210.63M26.62%59.55M
Total other finance cost --31.37M----------------------------13,922.34%40.81M----
Other net income (expense) 333.84%18.47M146.82%4.81M93.16%-6.49M-999.35%-143.86M-77.31%-30.8M-137.53%-7.9M-318.50%-10.27M-3,362.36%-94.9M95.30%-13.09M45.32%-17.37M
Gain on sale of security -250.88%-3.43M3,251.15%8.26M454.80%4.25M-509.69%-6.85M-434.83%-7.66M177.37%2.27M-162.23%-262K-162.97%-1.2M113.52%1.67M302.11%2.29M
Special income (charges) 282.07%20.67M64.81%-5.05M88.49%-11.26M-546.94%-148.8M-18.91%-25.31M-411.26%-11.35M-472.10%-14.36M-2,812.63%-97.78M91.92%-23M40.92%-21.28M
-Less：Restructuring and merger&acquisition -16.86%143K365.45%1.02M-61.16%571K111.18%1.43M96.79%-437K-95.87%172K103.50%220K-50.46%1.47M-545.58%-12.75M-683.52%-13.6M
-Less:Other special charges -286.15%-20.81M-71.51%4.03M-88.90%10.69M312.25%147.37M-26.19%25.74M675.30%11.18M483.94%14.14M24,594.10%96.31M-87.31%35.75M3.51%34.88M
Other non- operating income (expenses) 4.84%1.24M-63.21%1.6M-87.28%518K42.93%11.78M33.50%2.17M-35.77%1.18M945.56%4.36M-6.71%4.07M-55.36%8.24M-55.96%1.63M
Income before tax -133.87%-5.22M153.42%51.71M149.64%37.49M-36.61%-55.01M81.65%-15.32M-32.82%15.42M-31.20%20.41M-701.21%-75.52M83.77%-40.27M-990.28%-83.46M
Income tax -737.07%-23.36M345.02%16.1M109.03%12.87M123.18%18.86M-45.13%5.42M276.59%3.67M15,830.43%3.62M821.56%6.16M26.87%8.45M649.97%9.88M
Net income 54.22%18.13M112.13%35.61M130.14%24.62M-51.63%-73.88M77.78%-20.74M-53.03%11.76M-43.45%16.79M-709.17%-81.68M80.88%-48.72M-1,493.44%-93.34M
Net income continuous Operations 54.22%18.13M112.13%35.61M130.14%24.62M-51.63%-73.88M77.78%-20.74M-53.03%11.76M-43.45%16.79M-709.17%-81.68M80.88%-48.72M-1,493.44%-93.34M
Minority interest income 32.32%15.76M22.24%13.19M24.67%12.42M21.94%43.01M94.89%10.34M-22.40%11.91M-39.25%10.79M416.25%9.97M128.26%35.27M447.87%5.31M
Net income attributable to the parent company 1,618.59%2.37M273.99%22.42M113.31%12.2M-39.16%-116.89M68.49%-31.08M-101.61%-156K-49.70%5.99M-1,219.93%-91.64M35.38%-83.99M-2,176.69%-98.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1,618.59%2.37M273.99%22.42M113.31%12.2M-39.16%-116.89M68.49%-31.08M-101.61%-156K-49.70%5.99M-1,219.93%-91.64M35.38%-83.99M-2,176.69%-98.65M
Basic earnings per share 0.01250.00%0.07113.33%0.0420.83%-0.3875.00%-0.10-75.00%0.02-500.00%-0.344.19%-0.48-1,233.33%-0.4
Diluted earnings per share 0.01250.00%0.07113.33%0.0420.83%-0.3875.00%-0.10-75.00%0.02-500.00%-0.344.19%-0.48-1,233.33%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -